论文部分内容阅读
目的系统评价肺力咳合剂治疗小儿支气管肺炎的疗效和安全性。方法计算机检索2015年5月前国内肺力咳合剂治疗治疗小儿支气管肺炎的随机对照研究文献,采用Rev Man5.0软件进行meta分析。结果试验组临床疗效明显优于对照组[有效率:OR=4.49,95%CI:(2.95,6.84),Z=7.00,P<0.01;显效率:OR=1.97,95%CI:(1.32,2.95),Z=3.31,P<0.01];无明显不良反应。结论肺力咳合剂治疗小儿支气管肺炎的疗效好,安全性高。
Objective To systematically evaluate the efficacy and safety of “Pulmonary Decoction” in treating bronchial pneumonia in children. Methods A computer-controlled randomized controlled study of pulmonary qi mixture in the treatment of bronchial pneumonia in children before May 2015 was performed. The meta-analysis was performed by using Rev Man 5.0 software. Results The clinical efficacy of the experimental group was significantly better than that of the control group [OR = 4.49,95% CI: (2.95,6.84), Z = 7.00, P <0.01; significant efficiency: OR = 1.97,95% CI: 2.95), Z = 3.31, P <0.01]; no obvious adverse reactions. Conclusion Pulmonary cough mixture treatment of bronchial pneumonia in children with good efficacy and high safety.